Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Esmey Obeng

Physician Assistant Plano, TX Physician Assistant

NPI 1154983831 CMS profile 10914505

1700 Alma Dr Ste 580, Plano, TX 75075

Open in the dashboard

General payments

$10,217

512 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Esmey Obeng of Plano, TX is reported in the CMS Open Payments database as having received $10,217 across 512 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,392 66
2024 General $2,129 106
2023 General $1,994 106
2022 General $1,237 61
2021 General $3,466 173

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Esmey Obeng
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Esmey Obeng were reported at $1,392. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Esmey Obeng Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $3,466 $132 $37–$438 $132
2022 $1,237 $155 $48–$522 $149
2023 $1,994 $167 $52–$557 $160
2024 $2,129 $178 $55–$600 $164
2025 $1,392 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,822 113 payments
  2. ITI, Inc. $1,725 64 payments
  3. Otsuka America Pharmaceutical, Inc. $1,316 67 payments
  4. Teva Pharmaceuticals USA, Inc. $1,249 51 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $619 36 payments
  6. Lundbeck LLC $539 27 payments
  7. Janssen Pharmaceuticals, Inc $510 31 payments
  8. Ironshore Pharmaceuticals Inc. $381 27 payments
  9. Tris Pharma Inc $367 20 payments
  10. Axsome Therapeutics, Inc. $335 10 payments
  11. Other $1,354 66 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $9,845 507 payments
  2. Education $257 4 payments
  3. Consulting Fee $115 1 payment
Products named General payments · program years 2021–2025
  1. VRAYLAR $1,537 98 payments
  2. CAPLYTA Psychiatry $1,364 49 payments
  3. REXULTI Psychiatry $1,194 61 payments
  4. UZEDY $668 41 payments
  5. TRINTELLIX $619 36 payments
  6. REXULTI Psychiatry $516 26 payments
  7. ABILIFY MAINTENA $466 26 payments
  8. SPRAVATO $458 21 payments
  9. JORNAY PM $381 27 payments
  10. CAPLYTA Psychiatry $362 15 payments
  11. Other $3,519 170 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

512 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record